top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

PHARMA

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Despite positive long-term efficacy and safety data, the biopharma has concluded its OX40L antibody would not offer a meaningful improvement over current standards of care and will no longer pursue regulatory approval for the indication.

 Featured Articles. 

7-format11240.jpg
PHARMA

How Automation is Accelerating Drug Discovery Timelines

7-format11240.jpg
BIOTECH

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

7-format11240.jpg
PHARMA

AI in Science Writing and the Imitation of Understanding

7-format11240.jpg
HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

7-format11240.jpg
BIOTECH

Moving research out of the lab is key to UK life science success

7-format11240.jpg
BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

7-format11240.jpg
BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

7-format11240.jpg
HEALTH

The Risk AI Poses to Public Health

7-format11240.jpg
PHARMA

Pharma Smart Manufacturing 2026

 Latest News. 

24th July, 2026

01.

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Despite positive long-term efficacy and safety data, the biopharma has concluded its OX40L antibody would not offer a meaningful improvement over current standards of care and will no longer pursue regulatory approval for the indication.

21st July, 2026

02.

Kolon TissueGene's Knee Osteoarthritis Therapy Fails Phase 3 Trial

Second late-stage study due in October will decide the fate of the cell-based gene therapy programme.

17th July, 2026

03.

Hummingbird Bioscience wins APAC AI Discovery Award

Singapore-based Hummingbird Bioscience has been named the Asia Pacific Trailblazer Award winner at the 2026 Nebius AI Discovery Awards, recognising the company's AI-first approach to therapeutic discovery and development.

13th July, 2026

04.

ABM secures major multi-site contract supporting Ireland’s manufacturing sector

Facilities and engineering provider strengthens presence in regulated environments with technology-enabled approach to compliance and operational support

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page